AstraZeneca withdraws its COVID-19 vaccine worldwide – CBC

More than 3 billion doses of the vaccine supplied during early stage of pandemic

May 08, 2024

AstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global markets. The vaccine was used early on in the pandemic in many countries, including Canada.

In an update on the European Medicines Agency’s website on Wednesday, the regulator said that the approval for Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”

More than three billion doses of the vaccine have been supplied since it first was administered in the United Kingdom in January 2021.

AstraZeneca said as multiple vaccines against newer variants of the pandemic coronavirus have been developed, there is a surplus. Demand for Vaxzevria declined and the company said it is no longer being manufactured or supplied.

Read more: https://www.cbc.ca/news/health/astra-zeneca-covid-vaccine-1.7198111

NationTalk Partners & Sponsors Learn More